Tag Archive > Seronegative Patients

First-in-class Biologic Agent for Kidney Transplant Rejection Approved in Europe

Paris (ots/PRNewswire) – – European Commission approves NULOJIX(R) (belatacept), in combination with corticosteroids and a mycophenolic acid and an interleukin-2 receptor antagonist at induction, for prophylaxis of graft rejection in adult patients receiving a kidney transplant – First new mode of action for prevention of graft rejection in kidney transplantation in a decade – Similar [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,